Altera Brokers is a pharmaceutical brokerage and consulting firm that focuses on facilitating the acquisition, sale, and licensing of intellectual property assets while providing expert consulting services to optimize IP portfolios and strategies.

ABOUT ALTERA BROKERS

Altera Brokers is a pharmaceutical brokerage and consulting firm that focuses on facilitating the acquisition, sale, and licensing of intellectual property assets while providing expert consulting services to optimize IP portfolios and strategies.

Founded in 2024 by Dr. Edward Mena alongside a group of principal industry experts who possess extensive backgrounds in clinical research, pharmaceuticals, and asset valuations, the Altera Brokers team is able to offer valuable insights into emerging pharmaceutical innovations and therapies.

Altera Brokers' goal is to become a leading force in the pharmaceutical brokerage sector to drive advancements in pharmaceutical access, offer valuable guidance on pharmaceutical valuations that help clients optimize investments in medical resources, and improve healthcare outcomes for patients.

RESEARCH PAPERS & NEWS

Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis

Tropifexor plus Cenicriviroc Combination Versus Monotherapy in Nonalcoholic Steatohepatitis

Increased Accuracy in Identifying NAFLD with Advanced Fibrosis and Cirrhosis

Plasma Cell-Free DNA Methylation Markers for Hepatocellular Carcinoma Surveillance in Patients

Emricasan to Prevent New Decompensation in Patients with NASH-Related Decompensated Cirrhosis

Diagnosis of Focal Nodular Hyperplasia (FNH) after Liver Transplantation

Brain MR Spectroscopy Markers of Encephalopathy Due to Nonalcoholic Steatohepatitis